deltatrials
Completed PHASE1 INTERVENTIONAL NCT00002600

Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer

A PHASE I TRIAL OF HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE MARROW AND PERIPHERAL BLOOD PROGENITOR CELL RESCUE IN PATIENTS WITH PLATINUM-SENSITIVE, CHEMOTHERAPY-RESPONSIVE EPITHELIAL OVARIAN CARCINOMA

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cavity Cancer
Interventions autologous bone marrow transplantation carboplatin cyclophosphamide filgrastim peripheral blood stem cell transplantation
Updated 6 times since 2017 Last updated: Feb 4, 2019 Started: Oct 21, 1994 Primary completion: Jul 25, 2001 Completion: Jul 25, 2001
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00002600, this PHASE1 trial focuses on Fallopian Tube Cancer and Ovarian Cancer and remains completed. Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, it has been updated 6 times since 1994, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotCompleted~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Mar 2019 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jun 2018 — Mar 2019 [monthly]

    Completed PHASE1

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Oct 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Data source: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations